Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection Against Influenza Virus.

Nie J, Wang Q, Li C, Zhou Y, Yao X, Xu L, Chang Y, Ding F, Sun L, Zhan L, et al. Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection Against Influenza Virus. Adv Healthc Mater. 2023:e2303531.